# Surgery for Recurrent Glioblastoma

> **NCT02394626** · PHASE2 · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 120 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Surgery followed by adjuvant second-line therapy
- **PROCEDURE:** Second-line therapy alone

## Key facts

- **NCT ID:** NCT02394626
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-05-01
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02394626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02394626, "Surgery for Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02394626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*